Literature DB >> 15851734

Cognitive functioning in children and adolescents with multiple sclerosis.

W S MacAllister1, A L Belman, M Milazzo, D M Weisbrot, C Christodoulou, W F Scherl, T E Preston, C Cianciulli, L B Krupp.   

Abstract

OBJECTIVE: To examine cognitive functioning in children with multiple sclerosis (MS).
METHODS: The authors examined the neuropsychological profile of 37 children with a diagnosis of clinically definite MS and assessed the associations between cognitive function and clinical features.
RESULTS: Of 37 children and adolescents evaluated, 35% demonstrated significant cognitive impairment. Cognitive functioning was strongly related to several clinical variables, including current Expanded Disability Status Scale, total number of relapses, and total disease length. The consequences of MS adversely affected academic functioning in over a third of the children.
CONCLUSIONS: Cognitive deficits occur in children with multiple sclerosis. Comprehensive treatment planning should involve recognition that they may require academic accommodations for their education.

Entities:  

Mesh:

Year:  2005        PMID: 15851734     DOI: 10.1212/01.WNL.0000158474.24191.BC

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  51 in total

1.  Psychosocial issue in children and adolescents with multiple sclerosis.

Authors:  B Goretti; A Ghezzi; E Portaccio; S Lori; V Zipoli; L Razzolini; L Moiola; M Falautano; M F De Caro; R Viterbo; F Patti; R Vecchio; C Pozzilli; V Bianchi; M Roscio; G Comi; M Trojano; M P Amato
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

Review 2.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

3.  Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.

Authors:  L E Charvet; E H O'Donnell; A L Belman; T Chitnis; J M Ness; J Parrish; M Patterson; M Rodriguez; E Waubant; B Weinstock-Guttman; L B Krupp
Journal:  Mult Scler       Date:  2014-03-31       Impact factor: 6.312

Review 4.  Pediatric multiple sclerosis.

Authors:  E Ann Yeh; Tanuja Chitnis; Lauren Krupp; Jayne Ness; Dorothée Chabas; Nancy Kuntz; Emmanuelle Waubant
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

5.  Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study.

Authors:  M S Vishwas; T Chitnis; R Pienaar; B C Healy; P E Grant
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

Review 6.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

7.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

8.  The educational impact of childhood-onset multiple sclerosis: Why assessing academic achievement is imperative.

Authors:  W S Vargas; K G Noble; B Banwell; P De Jager
Journal:  Mult Scler       Date:  2020-05-28       Impact factor: 6.312

Review 9.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

10.  Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.

Authors:  Laura Julian; Dana Serafin; Leigh Charvet; Joseph Ackerson; Ralph Benedict; Ellen Braaten; Tanya Brown; Ellen O'Donnell; Joy Parrish; Thomas Preston; Michael Zaccariello; Anita Belman; Tanuja Chitnis; Mark Gorman; Jayne Ness; Marc Patterson; Moses Rodriguez; Emmanuelle Waubant; Bianca Weinstock-Guttman; Ann Yeh; Lauren B Krupp
Journal:  J Child Neurol       Date:  2012-11-15       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.